Merit Medical Systems, Inc. engages in the manufacture and market of proprietary disposable medical devices. It operates through Cardiovascular and Endoscopy segments. The Cardiovascular segment consists of peripheral intervention, cardiac intervention, interventional oncology and spine, and cardiovascular and critical care product groups. The Endoscopy segment integrates advanced non-vascular stent technology with balloon dilators, inflation devices, guide wires, procedure kits, and other devices that are used by gastroenterologists, endoscopists, pulmonologists, and thoracic and general surgeons. The company was founded by Fred P. Lampropoulos, Darla Gill, Kent W. Stanger and William Padilla in July 1987 and is headquartered in South Jordan, UT.
Industry, Sector and Symbol
Stock Exchange NASDAQ
Industry Surgical & medical instruments
Sub-IndustryHealth Care Supplies
SectorMedical
Current SymbolNASDAQ:MMSI
Previous Symbol
CUSIP58988910
Phone801-253-1600
Debt
Debt-to-Equity Ratio0.20
Current Ratio2.77
Quick Ratio1.47
Price-To-Earnings
Trailing P/E Ratio43.97
Forward P/E Ratio33.70
P/E Growth2.59
Sales & Book Value
Annual Sales$727.85 million
Price / Sales4.24
Cash Flow$2.3588 per share
Price / Cash Flow23.86
Book Value$13.47 per share
Price / Book4.18
Profitability
EPS (Most Recent Fiscal Year)$1.28
Net Income$27.52 million
Net Margins4.72%
Return on Equity10.86%
Return on Assets6.55%
Miscellaneous
Employees4,876
Outstanding Shares54,830,000
Market Cap$3.09 billion
OptionableOptionable
Merit Medical Systems (NASDAQ:MMSI) Frequently Asked Questions
What is Merit Medical Systems' stock symbol?
Merit Medical Systems trades on the NASDAQ under the ticker symbol "MMSI."
How were Merit Medical Systems' earnings last quarter?
Merit Medical Systems, Inc. (NASDAQ:MMSI) issued its quarterly earnings results on Thursday, October, 25th. The medical instruments supplier reported $0.47 EPS for the quarter, beating the Thomson Reuters' consensus estimate of $0.42 by $0.05. The medical instruments supplier earned $221.66 million during the quarter, compared to the consensus estimate of $217.62 million. Merit Medical Systems had a net margin of 4.72% and a return on equity of 10.86%. View Merit Medical Systems' Earnings History.
When is Merit Medical Systems' next earnings date?
What price target have analysts set for MMSI?
9 Wall Street analysts have issued 1 year price objectives for Merit Medical Systems' shares. Their predictions range from $58.00 to $79.00. On average, they anticipate Merit Medical Systems' stock price to reach $68.4444 in the next year. This suggests a possible upside of 21.6% from the stock's current price. View Analyst Price Targets for Merit Medical Systems.
What is the consensus analysts' recommendation for Merit Medical Systems?
9 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Merit Medical Systems in the last year. There are currently 1 sell rating and 8 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Merit Medical Systems.
Has Merit Medical Systems been receiving favorable news coverage?
Headlines about MMSI stock have been trending positive this week, InfoTrie reports. InfoTrie scores the sentiment of media coverage by reviewing more than six thousand blog and news sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores closest to five being the most favorable. Merit Medical Systems earned a media sentiment score of 3.0 on InfoTrie's scale. They also gave news headlines about the medical instruments supplier a news buzz of 8.0 out of 10, indicating that recent media coverage is very likely to have an effect on the stock's share price in the next several days.
Who are some of Merit Medical Systems' key competitors?
Some companies that are related to Merit Medical Systems include Teleflex (TFX), DexCom (DXCM), Hill-Rom (HRC), Haemonetics (HAE), Insulet (PODD), ICU Medical (ICUI), Globus Medical (GMED), Penumbra (PEN), Integra Lifesciences (IART), Novocure (NVCR), Cantel Medical (CMD), NuVasive (NUVA), Glaukos (GKOS), Tandem Diabetes Care (TNDM) and Irhythm Technologies (IRTC).
Who are Merit Medical Systems' key executives?
Merit Medical Systems' management team includes the folowing people:
- Fred P. Lampropoulos, Chairman, President & Chief Executive Officer
- Ronald A. Frost, Chief Operating Officer
- Raul Parra, Chief Financial Officer
- Joseph Pierce, Chief Information Officer
- Jason Treft, Chief Technology Officer
Who are Merit Medical Systems' major shareholders?
Merit Medical Systems' stock is owned by many different of institutional and retail investors. Top institutional investors include BlackRock Inc. (14.59%), Vanguard Group Inc. (9.64%), Vanguard Group Inc (9.64%), Dimensional Fund Advisors LP (3.78%), Eagle Asset Management Inc. (3.74%) and Partner Fund Management L.P. (2.46%). Company insiders that own Merit Medical Systems stock include A Scott Anderson, F Ann Millner, Franklin J Miller, Joseph Wright, Justin J Lampropoulos, Kent W Stanger, Michael E Stillabower, Nolan E Karras, Richard W Edelman and Ronald Frost. View Institutional Ownership Trends for Merit Medical Systems.
Which institutional investors are selling Merit Medical Systems stock?
MMSI stock was sold by a variety of institutional investors in the last quarter, including Dimensional Fund Advisors LP, JPMorgan Chase & Co., Royce & Associates LP, Man Group plc, Partner Fund Management L.P., Perceptive Advisors LLC, Eagle Boston Investment Management Inc. and Aristotle Capital Boston LLC. Company insiders that have sold Merit Medical Systems company stock in the last year include F Ann Millner, Franklin J Miller, Joseph Wright, Justin J Lampropoulos, Michael E Stillabower, Nolan E Karras and Ronald Frost. View Insider Buying and Selling for Merit Medical Systems.
Which institutional investors are buying Merit Medical Systems stock?
MMSI stock was purchased by a variety of institutional investors in the last quarter, including Point72 Asset Management L.P., BlackRock Inc., Vanguard Group Inc, Vanguard Group Inc., Peregrine Capital Management LLC, Kornitzer Capital Management Inc. KS, Thrivent Financial for Lutherans and Castleark Management LLC. View Insider Buying and Selling for Merit Medical Systems.
How do I buy shares of Merit Medical Systems?
Shares of MMSI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Merit Medical Systems' stock price today?
One share of MMSI stock can currently be purchased for approximately $56.28.
How big of a company is Merit Medical Systems?
Merit Medical Systems has a market capitalization of $3.09 billion and generates $727.85 million in revenue each year. The medical instruments supplier earns $27.52 million in net income (profit) each year or $1.28 on an earnings per share basis. Merit Medical Systems employs 4,876 workers across the globe.
What is Merit Medical Systems' official website?
How can I contact Merit Medical Systems?
Merit Medical Systems' mailing address is 1600 WEST MERIT PARK WAY, SOUTH JORDAN UT, 84095. The medical instruments supplier can be reached via phone at 801-253-1600 or via email at [email protected]
MarketBeat Community Rating for Merit Medical Systems (NASDAQ MMSI)
MarketBeat's community ratings are surveys of what our community members think about Merit Medical Systems and other stocks. Vote "Outperform" if you believe MMSI will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MMSI will underperform the S&P 500 over the long term. You may vote once every thirty days.
